In this podcast series, our expert panel of health professionals will discuss the available data and their professional experience in the management of Spinal Muscular Atrophy (SMA).

This podcast and video series is intended for healthcare practitioners located in Australia.

SPINRAZA® (nusinersen) is discussed; please refer to the Product Information prior to prescribing.

Learning outcomes

By the end of each episode, listeners will be able to:

Episode 1: Diagnosing SMA

  1. Distinguish between the clinical manifestations, genetic etiology, and diagnostic criteria of SMA and various types of muscular dystrophy.
  2. Demonstrate the ability to accurately diagnose SMA while effectively ruling out various forms of muscular dystrophy in order to formulate tailored management plans based on accurate diagnosis and prognosis.

Episode 2: How to get the most from SMA review consultations

  1. Approach the delicate task of discussing an incurable disease with a someone living with SMA.
  2. Describe the role of Active Listening in difficult conversations and effective communication.

Episode 3: How a holistic approach may improve SMA care

  1. Apply a holistic approach to the management of SMA.
  2. Evaluate the role of allied health and palliative care.

Episode 4: Assessing SMA treatment effectiveness and disease progression

  1. Assess the potential for functional improvement across the phenotypic spectrum of adult SMA.
  2. Evaluate treatment outcomes in contrast to the natural course of the disease.

Any Australian registered healthcare professional may enrol in this podcast and video series.

START LEARNING

If you do not already have an account with Arterial Education, you will be required to create one. This verifies that you are a healthcare professional and allows you to log your learning activities.